Not rendering correctly? View this email as a web page here.
email_banner.jpg
newsletter banner 6.11.17.jpg

WSJ: Virtual reality being used in industries from construction to

medicine to train for risky jobs

The use of virtual reality is spreading especially quickly through medicine. VR 3-D modeling of the brain developed by OurCrowd portfolio company, Surgical Theater, is already being used for planning and practicing neurosurgeries in hospitals at New York University, University Hospitals in Cleveland and Mount Sinai among others.
Read more
Cyberweek newsletter banner.jpg

OurCrowd & Portfolio Companies in the News
Freightos new logo-2.png
Freightos featured in

Air Cargo News

mPrest-2.jpg
mPrest featured in

Computer World

BriefCam-2.png
BriefCam featured in

American Security Today

calendar-01-01-01.jpg


Explore our worldwide events in the OurCrowd calendar

OurCrowd is hosting investor events across the globe in the upcoming months, featuring guest speakers and CEOs of our latest investment opportunities.
BROWSE EVENTS
 
banner_1106.jpg

Mobileye posts 66% jump in Q1 revenue

Revenue went from $75.2 million in the first quarter of 2016 to $124.7 million in the first quarter of this year.

Read more

Save the Date: OurCrowd Global Investor Summit 2018

This year's Summit will take place on Thursday, February 1st, 2018. Super-early registration just opened so save your spot.

Register now

NAB private banking in alliance with Israel's OurCrowd

Clients of National Australia Bank's private bank will get special access to venture capital raisings by global technology companies, with NAB and the Israeli equity crowdfunding platform OurCrowd announcing a collaboration deal on Sunday.

Read more
News Nuggets
  • Israeli app lets you record your past (Jerusalem Post)
  • Novel therapy could prevent heart failure (Israel21c)
  • Israeli startup Belkin Laser raises $5M (NoCamels)
  • Israeli device simplifies hernia surgery and recovery (Israel21c)
  • Somoto to buy American video ad company for $14.5M (Globes)
 
You received this email because you are subscribed to OurCrowd Weekly Newsletter from OurCrowd. Update your email preferences to choose the types of emails you receive. Unsubscribe from all future emails